The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Intervet competitive analysis

Loading summary...

Latest oppositions filed by Intervet

Explore patent oppositions filed by Intervet against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3148576
Vaccine Composition Against Streptococcus Suis InfectionCEVA SANT ANIMALEJul 27, 2021
EP3344289
Pestivirus Vaccines For Congenital TremorsBOEHRINGER INGELHEIM VETMEDICAOct 28, 2020
EP2873733
Vectors For Transforming Mycoplasma Hyopneumoniae, Transformed M. Hyopneumoniae Strains, And Use ThereofHIPRA SCIENTIFICMar 26, 2020
EP2785374
Recombinant Gallid Herpesvirus 3 (Mdv Serotype 2) Vectors Expressing Antigens Of Avian Pathogens And Uses ThereofBOEHRINGER INGELHEIM ANIMAL HEALTH USASep 30, 2019
EP2998315
Newcastle Disease Virus Vectored Avian VaccinesBOEHRINGER INGELHEIM ANIMAL HEALTH USAJul 10, 2019
EP2931741
Porcine Parvovirus 5A, Methods Of Use And VaccineBOEHRINGER INGELHEIM ANIMAL HEALTH USAApr 23, 2019
EP2992897
Immunogenic Compositions Comprising Lawsonia IntercellularisBOEHRINGER INGELHEIM ANIMAL HEALTH USAApr 2, 2019
EP1968630
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such CompositionsBOEHRINGER INGELHEIM ANIMAL HEALTH USAOct 23, 2018
EP2957284
Animal Pest Control MethodE I DU PONT DE NEMOURSOct 17, 2018
EP2874653
Method Of Providing Protective Immunity Against Heterologous Leptospira StrainsBOEHRINGER INGELHEIM ANIMAL HEALTH USASep 26, 2018

Latest patents of Intervet opposed by its competitors

Explore Intervet's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2658542
Jun 4, 2025Topical Localized Isoxazoline Formulation1
EP3236960
Jan 29, 2025Use Of Isoxazoline Compounds For Treating Demodicosis2
EP2833866
Nov 27, 2024Soft Chewable Pharmaceutical Products2
EP3707128
Dec 20, 2023Injectable Isoxazoline Pharmaceutical Compositions And Their Use Against Parasite Infestation1
EP4153133
Nov 8, 2023Injectable Pharmaceutical Compositions And Uses Thereof1
EP2688587
Aug 16, 2023Salmonid Alphavirus Vaccine1
EP3049108
Jun 21, 2023Dry Formulations Of Vaccines That Are Room Temperature Stable1
EP2833867
May 10, 2023Solid Oral Pharmaceutical Compositions For Isoxazoline Compounds2
EP2545777
Jan 18, 2023Isoxazoline Compositions And Their Use As Antiparasitics2
EP3883603
Dec 21, 2022A Vaccine For Protection Against Streptococcus Suis1

Latest PTAB cases involving Intervet

Discover the latest PTAB cases involving Intervet, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 15, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Intervet

IPR2019-00374Nov 30, 2018INTERVETBOEHRINGER INGELHEIM VETMEDICAInstitution Denied
IPR2019-00381Nov 30, 2018INTERVETBOEHRINGER INGELHEIM VETMEDICATerminated-Settled
IPR2018-01788Sep 24, 2018INTERVETBOEHRINGER INGELHEIM VETMEDICAInstitution Denied
IPR2018-01789Sep 24, 2018INTERVETBOEHRINGER INGELHEIM VETMEDICAInstitution Denied
IPR2018-00919Apr 13, 2018MERIALINTERVETInstitution Denied

Peer Comparison New

IP litigation analysis comparing Intervet with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
INTERVET113641
BOEHRINGER INGELHEIM ANIMAL HEALTH USA16302 -
BOEHRINGER INGELHEIM VETMEDICA1829 - 4
MERIAL - 641